Related Experiment Video

Updated: Aug 24, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Selective estrogen receptor modulator regulated proteins in endometrial cancer cells

Yatrik M Shah1, Venkatesha Basrur, Brian G Rowan

  • 1Department of Biochemistry & Molecular Biology, Medical College of Ohio, 3035 Arlington Avenue, Toledo, OH 43614-5804, USA.

Molecular and Cellular Endocrinology
|May 20, 2004
PubMed

Insights

Tamoxifen therapy for breast cancer can cause endometrial proliferation. Researchers identified nine proteins linked to this growth, offering potential biomarkers for selective estrogen receptor modulator (SERM) response.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Tamoxifen is a key hormonal therapy and chemopreventative for breast cancer.
  • A significant side effect of tamoxifen is undesirable endometrial proliferation.
  • Understanding tamoxifen's effects on the endometrium is crucial for patient safety.

Purpose of the Study:

  • To identify proteins associated with tamoxifen's growth-stimulatory effects in an ER-positive endometrial model.
  • To investigate protein regulation by estradiol and selective estrogen receptor modulators (SERMs).

Main Methods:

  • Utilized two-dimensional gel electrophoresis to profile proteins in the Ishikawa endometrial adenocarcinoma cell line.
  • Incubated cells with estradiol, 4-hydroxytamoxifen, and EM-652 (Acolbifene) for 24 hours.
  • Analyzed changes in total cellular and secreted protein expression.

Main Results:

  • Nine proteins showed a significant increase in expression following treatment with estradiol and SERMs.
  • Identified proteins include heat shock proteins (90-alpha, -beta), heterogeneous nuclear ribonucleoprotein F, RNA polymerase II-mediating protein, cytoskeletal keratins (8, 18), ubiquitin-conjugating enzyme E2-18 kDa, and nucleoside diphosphate kinase B.
  • These proteins are regulated by estrogen and SERMs in endometrial cells.

Conclusions:

  • The identified protein profiles may serve as novel biomarkers for SERM response.
  • These findings offer insights into the mechanisms underlying SERM-mediated endometrial growth.
  • Further research can explore these proteins for predicting or monitoring tamoxifen therapy outcomes.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...